|
Volumn 59, Issue 1 SUPPL. 1, 2012, Pages
|
Précis: An introduction to end-stage renal disease in the United States
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANTIANEMIC AGENT;
ATORVASTATIN;
CALCIUM ACETATE;
CARVEDILOL;
CINACALCET;
CLONIDINE;
CLOPIDOGREL;
ESOMEPRAZOLE;
FUROSEMIDE;
GABAPENTIN;
HYDRALAZINE;
HYDROCODONE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LEVOTHYROXINE;
LISINOPRIL;
METOCLOPRAMIDE;
METOPROLOL;
NIFEDIPINE;
OMEPRAZOLE;
PANTOPRAZOLE;
SEVELAMER;
SIMVASTATIN;
VALSARTAN;
WARFARIN;
ZOLPIDEM;
ANEMIA;
ANGIOPLASTY;
ARTICLE;
CATHETER INFECTION;
CHRONIC KIDNEY DISEASE;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DRUG COST;
HEART ATRIUM FIBRILLATION;
HEMODIALYSIS;
HEMOGLOBIN BLOOD LEVEL;
HOSPITALIZATION;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
NEPHROLOGIST;
PATIENT CARE;
PERITONEAL DIALYSIS;
PERITONITIS;
RISK FACTOR;
SEPSIS;
|
EID: 83755180839
PISSN: 02726386
EISSN: 15236838
Source Type: Journal
DOI: 10.1053/j.ajkd.2011.10.025 Document Type: Article |
Times cited : (1)
|
References (0)
|